Clinical Trial

Exploring the Eye Care Benefits of Cordyceps Cicadae Across Different Age Groups

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 21, 2025 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this study is to evaluate the underlying mechanisms of consuming two capsules (each containing 250 mg of Cordyceps cicadae mycelium, for a total intake of 500 mg) of Grape King's Cordyceps cicadae mycelium through a clinical human trial. By including participants from different age groups, the study investigates whether improvements in visual acuity and the alleviation of eye fatigue are associated with changes in ocular accommodation, tear film stability, and blood circulation. The ultimate goal is to develop a health supplement beneficial for vision.
Trial Details
NCT Number NCT07135180
Lead Sponsor China Medical University Hospital
Conditions Visual Acuity, Accommodation, Dry Eye
Enrollment 200 participants
Start Date 2025-07-01
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-21